Mariathasan et al. [16] and Tauriello et al. [17] recently demonstrated that stromal cancer-associated fibroblasts (CAFs) are the major cell source and responders to TGFβ signaling in colon and urothelial carcinomas, respectively. This evidence concerns the gene TGFB1 and urothelial carcinoma.